Why Combine Drugs?
Pharmacological blood pressure reduction is often perceived by the body not as a therapeutic process, but as a pathology. In response, protective systems are immediately activated. The main barrier to stable pressure control is compensatory sodium and water retention.
This is why diuretics are essential in treatment regimens. Combining them with other antihypertensive agents achieves two key goals:
- Elimination of fluid retention provoked by other hypotensive drugs. This prevents so-called "pseudotolerance" to treatment.
- Potentiation of the effect of concurrent therapy. Diuretics help normalize the electrolyte balance directly within the vascular wall, making blood vessels more responsive to drug action.
Mechanisms of Compensatory Fluid Retention
Blood pressure reduction triggers sodium and water retention mechanisms via two primary physiological systems:
- Renin-Angiotensin-Aldosterone System (RAAS). The cascade begins when a drop in pressure causes a decrease in renal blood flow. The kidneys respond by increasing renin secretion. Renin triggers angiotensin II formation. This peptide then stimulates adrenal AT_1 receptors, leading to increased aldosterone secretion. The ultimate result of this cascade is pronounced sodium and water retention, counteracting the drug effects.
- Volume Control System. Concurrently with blood pressure reduction, specific receptors—"low-pressure sensors" (or "volume sensors")—are stimulated. Their activation triggers reflex fluid retention mechanisms aimed at correcting the apparent blood volume deficit.
Fixed-Dose Combinations
Clinical practice widely utilizes ready-made dosage forms containing fixed doses of multiple components. Classic combinations are primarily based on the sympatholytic reserpine. They provide synergistic action and patient convenience.
The Adelphane product line clearly demonstrates the principle of therapy intensification:
- Base combination: Adelphane. Includes the sympatholytic reserpine (0.0001 g) and the direct-acting vasodilator dihydralazine (0.01 g).
- Triple combination: Adelphane-Esidrix. The base composition is reinforced with the diuretic hydrochlorothiazide (0.01 g) to combat fluid retention.
- Quadruple combination: Adelphane-Esidrix-K. The composition is further enhanced with an electrolyte-correcting component—potassium chloride (0.6 g). This is necessary to prevent thiazide diuretic-induced hypokalemia.
Other Fixed Combinations:
- Triresid K: An equivalent of the quadruple combination offering complex action with potassium correction. It contains reserpine, dihydralazine sulfate, hydrochlorothiazide, and potassium chloride.
- Crystepin: An alternative combination of the sympatholytic reserpine, the diuretic clopamide, and the ergot alkaloid dihydroergotoxine.